A Prospective Open-label, Multicentric, Phase IV Trial to Compare the Efficacy of 10-Week Therapy of Ramipril and Indapamide SR Tablets Given Concomitantly with that of the Monotherapy of Ramipril or Indapamide SR in the Treatment of Hypertensive Patients whose Blood Pressure is Not Controlled by Monotherapy
Latest Information Update: 12 Sep 2024
At a glance
- Drugs Indapamide (Primary) ; Ramipril (Primary) ; Captopril
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Egis Pharmaceuticals
Most Recent Events
- 12 Sep 2024 This trial has been completed in Hungary, according to European Clinical Trials Database record.
- 26 Nov 2021 Planned number of patients changed from 226 to 221.
- 19 Jun 2019 New trial record